With the acquisition, Cipla gets a ready base to launch, promote and distribute products to the government and institutions in the US, while adding $225 million in sales to own revenue, giving it more scale and reach.<br />

Cipla: the American dream

2 min read . 16 Sep 2015
Cipla said that its overseas business was affected partly due to supply constraints, and the effect of a transition from a B2B model to a direct selling model. Photo: S. Kumar/Mint<br />

Cipla’s exports hit a supply wall

1 min read . 13 Feb 2015
The bulk drug business continued to underperform due regulatory issues affecting supplies to the US. Photo: Pradeep Gaur/Mint<br />

Ranbaxy’s US revenues take a dip

2 min read . 29 Jan 2015